# LEU — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-07-24. Informational only, not financial advice.

**Recommendation:** HOLD

**Scores (0–100):** Overall 5.7 · Fundamentals 5.8 · Technicals 5.2 · Growth 7.8 · Risk 7.5

## Summary

Centrus retains genuine strategic scarcity as the sole U.S.-licensed HALEU enricher with a $1.07B DOE contract, $900M Piketon task order, and $1.87B cash — but at $170.78 it trades ~44x forward P/E and ~65x EV/EBITDA while burning ~$58M/quarter in FCF, with a binary Aug 4 earnings print 11 days out. The bounce from $142 to $170 has retraced into prior supply and the 50DMA; risk/reward across the print is unattractive, and I stay HOLD with sizing discipline into the event.

## Price targets (6-month horizon)

- Bear: $135.00
- Base: $172.00
- Bull: $215.00

## News context

The material signal in the news flow is the July 8 finalization of the $900M fixed-price DOE HALEU task order (part of the broader $1.07B enrichment agreement) — this shifts Piketon from a demonstration pilot to a commercial-scale supply commitment and is the clearest de-risking of the multi-year revenue runway. Analyst posture is mixed but constructive: Truist initiated Buy with a $215 target, Needham maintained Buy but cut target from $314 to $264, and B of A stayed Neutral, cutting target from $240 to $205. The Simply Wall St piece flags the DOE contract as materially altering the investment case, which is fair, but it doesn't change near-term FCF math. Institutional ownership climbed +6.8pp to 78.4% in 45 days, consistent with S&P SmallCap 600 inclusion driving passive/index bid.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/leu-ai-stock-forecast-553b917fd7766104ef6ea3da5a47fef4
- AI-generated; model outputs can be wrong. Not financial advice.